76
|
Schwingshackl L, Hoffmann G. Higher- versus lower-protein diets. Eur J Clin Nutr 2012; 66:1372-3; author reply 1375. [PMID: 23093342 DOI: 10.1038/ejcn.2012.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
77
|
Fink T, Hartmann L, Hoffmann G. I116 INCONTINENCE AFTER PROLAPSE SURGERY. Int J Gynaecol Obstet 2012. [DOI: 10.1016/s0020-7292(12)60146-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
78
|
Adamczyk L, Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Banerjee A, Barnovska Z, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Brandin AV, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Butterworth J, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Chwastowski J, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derradi de Souza R, Dhamija S, Didenko L, Ding F, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Eun L, Evdokimov O, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Gliske S, Gorbunov YN, Grebenyuk OG, Grosnick D, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Horvat S, Huang B, Huang HZ, Huck P, Humanic TJ, Huo L, Igo G, Jacobs WW, Jena C, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kesich A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Luo X, Luszczak A, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Morozov B, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nogach LV, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pan YX, Pandit Y, Panebratsev Y, Pawlak T, Pawlik B, Pei H, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Powell CB, Prindle D, Pruneau C, Pruthi NK, Przybycien M, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Riley CK, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma B, Sharma M, Shi SS, Shou QY, Sichtermann EP, Singaraju RN, Skoby MJ, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Turnau J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Vossen A, Wada M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xin K, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yi Y, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Directed flow of identified particles in Au+Au collisions at √[SNN]=200 GeV at RHIC. PHYSICAL REVIEW LETTERS 2012; 108:202301. [PMID: 23003142 DOI: 10.1103/physrevlett.108.202301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/16/2011] [Indexed: 06/01/2023]
Abstract
STAR's measurements of directed flow (v1) around midrapidity for π±, K±, KS0, p, and p[over ¯] in Au+Au collisions at √[sNN]=200 GeV are presented. A negative v1(y) slope is observed for most of produced particles (π±, K±, KS0, and p[over ¯]). In 5%-30% central collisions, a sizable difference is present between the v1(y) slope of protons and antiprotons, with the former being consistent with zero within errors. The v1 excitation function is presented. Comparisons to model calculations (RQMD, UrQMD, AMPT, QGSM with parton recombination, and a hydrodynamics model with a tilted source) are made. For those models which have calculations of v1 for both pions and protons, none of them can describe v1(y) for pions and protons simultaneously. The hydrodynamics model with a tilted source as currently implemented cannot explain the centrality dependence of the difference between the v1(y) slopes of protons and antiprotons.
Collapse
|
79
|
Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Barnby LS, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Braidot E, Brandin AV, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Sánchez MCDLB, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Leyva AD, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derevschikov AA, de Souza RD, Didenko L, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Estienne M, Eun L, Evdokimov O, Fachini P, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk OG, Grosnick D, Gupta A, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Jacobs WW, Jena C, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Lukashov EV, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Pei H, Peitzmann T, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma M, Shi SS, Shou QY, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, de Toledo AS, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhan W, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Identified hadron compositions in p+p and Au+Au collisions at high transverse momenta at √S(NN)=200 GeV. PHYSICAL REVIEW LETTERS 2012; 108:072302. [PMID: 22401197 DOI: 10.1103/physrevlett.108.072302] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/04/2011] [Indexed: 05/31/2023]
Abstract
We report transverse momentum (p(T)≤15 GeV/c) spectra of π(±), K(±), p, p[over ¯], K(S)(0), and ρ(0) at midrapidity in p+p and Au+Au collisions at √S(NN)=200 GeV. Perturbative QCD calculations are consistent with π(±) spectra in p+p collisions but do not reproduce K and p(p[over ¯]) spectra. The observed decreasing antiparticle-to-particle ratios with increasing p(T) provide experimental evidence for varying quark and gluon jet contributions to high-p(T) hadron yields. The relative hadron abundances in Au+Au at p(T)≳8 GeV/c are measured to be similar to the p+p results, despite the expected Casimir effect for parton energy loss.
Collapse
|
80
|
Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Barnby LS, Beavis DR, Behera NK, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Braidot E, Brandin AV, Bridgeman A, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Sánchez MCDLB, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung P, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Leyva AD, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derevschikov AA, de Souza RD, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du CM, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Estienne M, Eun L, Evdokimov O, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk OG, Grosnick D, Gupta A, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heinz M, Heppelmann S, Hirsch A, Hjort E, Hoffmann GW, Hofman DJ, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Jacobs P, Jacobs WW, Jena C, Jin F, Jones PG, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Knospe AG, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Krueger K, Krus M, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li N, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Liu H, Liu J, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Lukashov EV, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Manweiler R, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nayak TK, Nelson JM, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Pei H, Peitzmann T, Perkins C, Peryt W, Pile P, Planinic M, Ploskon MA, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Potukuchi BVKS, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schaub J, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma M, Shi SS, Shou QY, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, de Toledo AS, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhan W, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Strangeness enhancement in Cu-Cu and Au-Au collisions at √S(NN)=200 GeV. PHYSICAL REVIEW LETTERS 2012; 108:072301. [PMID: 22401196 DOI: 10.1103/physrevlett.108.072301] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/15/2011] [Indexed: 05/31/2023]
Abstract
We report new STAR measurements of midrapidity yields for the Λ, Λ[over ¯], K(S)(0), Ξ(-), Ξ[over ¯](+), Ω(-), Ω[over ¯](+) particles in Cu+Cu collisions at √S(NN)==200 GeV, and midrapidity yields for the Λ, Λ[over ¯], K(S)(0) particles in Au+Au at √S(NN)==200 GeV. We show that, at a given number of participating nucleons, the production of strange hadrons is higher in Cu+Cu collisions than in Au+Au collisions at the same center-of-mass energy. We find that aspects of the enhancement factors for all particles can be described by a parametrization based on the fraction of participants that undergo multiple collisions.
Collapse
|
81
|
Petzina R, Hoffmann G, Kim YI, Scheid M, Schöttler J, Lutter G, Schöneich F, Rahimi A, Cremer J. ZipFix sternal closure system – single-centre experience in 20 patients and how to use it. Thorac Cardiovasc Surg 2012. [DOI: 10.1055/s-0031-1297646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
82
|
Schoeneich F, Rahimi A, Eide M, Grothusen C, Hoffmann G, Schöttler J, Cremer J. Transatrial left ventricular cannulation for arterial return to manage retrograde type A dissection in minimally invasive mitral valve surgery. Thorac Cardiovasc Surg 2012. [DOI: 10.1055/s-0031-1297652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
83
|
Schoeneich F, Rahimi A, Eide M, Grothusen C, Hoffmann G, Schöttler J, Cremer J. Transatrial left ventricular cannulation for arterial return in CABG with severe aortic calcification. Thorac Cardiovasc Surg 2012. [DOI: 10.1055/s-0031-1297707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
84
|
Teufel U, Engelmann G, Flechtenmacher C, Peccerella T, Millonig G, Hoffmann G, Mueller S, Seitz HK. Detection of highly carcinogenic, exocyclic etheno-DNA-adducts in the liver of children with non-alcoholic fatty liver disease. ZEITSCHRIFT FUR GASTROENTEROLOGIE 2012. [DOI: 10.1055/s-0031-1295833] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
85
|
Cremer J, Schöttler J, Petzina R, Hoffmann G. Stented bioprostheses in aortic position. HSR PROCEEDINGS IN INTENSIVE CARE & CARDIOVASCULAR ANESTHESIA 2012; 4:83-7. [PMID: 23439380 PMCID: PMC3484933] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
INTRODUCTION Biological stented prostheses are currently the main type of prosthetic valve used for aortic valve replacement. The ratio of bioprotheses to mechanical prostheses has switched in the last 15 years; the percentage of biological prostheses implanted has risen from 30 % to 85 %. Moreover the total number of implanted stented bioprostheses remained stable over the last years despite competing procedures like stentless prostheses or transcatheter aortic valve implantation. METHODS A literature search of all published aortic valve replacement studies was performed from January 2000 through May 2012. RESULTS The recommendations guiding the type of heart valve replacement have been revised in recent years. Of particular interest are the new generation of biological prostheses with extended durability, a decrease in mortality of reoperation and an increase in life expectancy. Comorbidities such as chronic renal insufficiency or chronic atrial fibrillation are no longer contraindications to bioprostheses. CONCLUSION Overall, even in face of more innovative biological alternatives the implantation of stented bioprostheses is still a very interesting option and represents actually the most frequent valve implantation technique for aortic stenosis.
Collapse
|
86
|
Hoffmann G, Wagels E, Kräft S, Goossens L, Ammon C, Georg H, Feige K. Comparative study of horses in tie stalls, individual housing in boxes and group housing. PFERDEHEILKUNDE 2012. [DOI: 10.21836/pem20120608] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
87
|
Schwingshackl L, Strasser B, Hoffmann G. Effects of monounsaturated fatty acids on cardiovascular risk factors: a systematic review and meta-analysis. ANNALS OF NUTRITION AND METABOLISM 2011; 59:176-86. [PMID: 22142965 DOI: 10.1159/000334071] [Citation(s) in RCA: 99] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2011] [Accepted: 09/14/2011] [Indexed: 01/22/2023]
Abstract
The appropriate pattern of macronutrient distribution for dietary protocols aimed at treating or preventing obesity and its associated cardiovascular diseases is still a controversial topic of discussion. Recommendations considering a specific percentage or range for monounsaturated fatty acids (MUFA) are rare. It was the aim of this study to analyze long-term, randomized, controlled dietary intervention trials and to investigate the effects of MUFA on the biomarkers of obesity and cardiovascular risk factors. Dietary regimens with a high amount of MUFA (>12%) were compared to those with ≤12%. The biomarkers taken into account were weight, waist circumference, fat mass, total cholesterol, LDL cholesterol, HDL cholesterol, triacylglycerols, systolic and diastolic blood pressure, as well as C-reactive protein. A total of 12 studies met the inclusion criteria. Data analysis was performed using the Review Manager 5.0.25 software. Significant differences between high- and low-MUFA protocols could be observed with respect to fat mass [-1.94 kg (confidence interval -3.72, -0.17), p = 0.03], systolic blood pressure [-2.26 mm Hg (confidence interval -4.28, -0.25), p = 0.03] and diastolic blood pressure [-1.15 mm Hg (confidence interval -1.96, -0.34), p = 0.005] favoring the dietary protocols with >12% MUFA. Therefore, MUFA might represent a useful tool in the design of dietary regimens for obesity and cardiovascular disease.
Collapse
|
88
|
Woltering R, Münster W, Hoffmann G, Heudorf U. [New approaches to the monitoring of hospital hygiene: assessment of hygiene skills of staff members by structured interviews and observation]. DAS GESUNDHEITSWESEN 2011; 73:810-4. [PMID: 22095027 DOI: 10.1055/s-0031-1285896] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
Abstract
INTRODUCTION Increasing demands on hygiene in hospitals require improved methods of systematic monitoring by the Public Health Service. METHODS The hygiene skills of at least 20% of the hospital physicians and nurses were evaluated by structured interviews and observation. The results were presented to the hospitals. RESULTS In total, 184 persons were reviewed in 5 hospitals. On average, 7 out of 10 questions on hygiene knowledge were answered correctly, 74% of the persons asked demonstrated proper hand hygiene and 66% of them were not wearing any jewellery on their hands. There were no significant differences between physicians and nurses. The slight differences between the 5 hospitals were transferred into a ranking. CONCLUSIONS The application of the method provides additional information on hygiene in hospitals and allows a comparison of the hygiene skills of their staff members. The results form the basis for a dialogue between hospital and Public Health Service.
Collapse
|
89
|
Sjolte J, Hoffmann G, Johnsen SJ, Vinther BM, Masson-Delmotte V, Sturm C. Modeling the water isotopes in Greenland precipitation 1959–2001 with the meso-scale model REMO-iso. ACTA ACUST UNITED AC 2011. [DOI: 10.1029/2010jd015287] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
90
|
Von Minckwitz G, Darb-Esfahani S, Loibl S, Huober JB, Tesch H, Solbach C, Holms F, Eidtmann H, Diedrich K, Just M, Clemens M, Hanusch C, Schrader I, Henschen S, Hoffmann G, Tiemann K, Diebold K, Untch M, Denkert C. Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer: Results from the GeparQuattro study (GBG 40). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.27_suppl.6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
6 Background: Adjacent ductal carcinoma in situ (DCIS) is in found in approximately 45% of invasive ductal carcinomas (IDC) of the breast. Pure DCIS overexpresses HER2 in approximately 45%. There is uncertainty whether adjacent DCIS impacts on the response to neoadjuvant chemotherapy and trastuzumab as well as whether HER2 expression in IDC component or adjacent DCIS changes throughout treatment. Methods: Core biopsies and surgical tissue from participants of the GeparQuattro study with HER2-positive IDC were centrally examined for the area of invasive ductal component and adjacent DCIS before and after receiving neoadjuvant anthracycline-taxane-trastuzumab containing chemotherapy. HER2 overexpression in IDC and adjacent DCIS was quantified separately by immunohistochemistry using the Ventana automated staining system. Pathological complete response (pCR) was defined as no residual invasive or non-invasive tumor tissue. Results: Fifty nine (37.3%) of 158 IDCs presented with adjacent DCIS at diagnosis. These tumors showed lower regression grades than pure IDC (p=0.033). Presence of adjacent DCIS was an independent negative predictor of pCR (odds ratio 0.42 [95% CI 0.2-0.9], p=0.027). Adjacent DCIS area decreased from pre-treatment to surgery (r=0.205) with 30 (50.8%) IDCs with adjacent DCIS showing complete eradication of adjacent DCIS. HER2 status of adjacent DCIS was highly correlated with HER2 status of IDC component before (r=0.892) and after treatment (r=0.676). Degree of HER2 overexpression of the IDC component decreased in 16 (33.3%) out of 49 patients without a pCR. These 16 IDCs showed lower RGs compared to the 33 IDCs with unchanged HER2 expression (p=0.055). Conclusions: HER2-positive IDCs with adjacent DCIS is less responsive to neoadjuvant chemotherapy and trastuzumab compared to pure IDC. However, complete eradication of adjacent DCIS is frequently observed. HER2-overexpression of the invasive ductal component decreases in a subset of tumors, which showed less tumor regression.
Collapse
|
91
|
Schwingshackl L, Strasser B, Hoffmann G. Effects of Monounsaturated Fatty Acids on Glycaemic Control in Patients with Abnormal Glucose Metabolism: A Systematic Review and Meta-Analysis. ANNALS OF NUTRITION AND METABOLISM 2011; 58:290-6. [DOI: 10.1159/000331214] [Citation(s) in RCA: 105] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/13/2011] [Accepted: 07/20/2011] [Indexed: 11/19/2022]
|
92
|
Förster T, Hoffmann G. Die Viskositätsabhängigkeit der Fluoreszenzquantenausbeuten einiger Farbstoffsysteme. ACTA ACUST UNITED AC 2011. [DOI: 10.1524/zpch.1971.75.1_2.063] [Citation(s) in RCA: 419] [Impact Index Per Article: 32.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
93
|
Schumann H, Calow T, Weckesser S, Müller M, Hoffmann G. Water-filtered infrared A for the treatment of chronic venous stasis ulcers of the lower legs at home: a randomized controlled blinded study. Br J Dermatol 2011; 165:541-51. [DOI: 10.1111/j.1365-2133.2011.10410.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
94
|
Torun AR, Hoffmann G, Mountasir A, Cherif C. Effect of twisting on mechanical properties of GF/PP commingled hybrid yarns and UD-composites. J Appl Polym Sci 2011. [DOI: 10.1002/app.34458] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
95
|
von Felbert V, Kernland-Lang K, Hoffmann G, Wienert V, Simon D, Hunziker T. Irradiation with water-filtered infrared A plus visible light improves cutaneous scleroderma lesions in a series of cases. Dermatology 2011; 222:347-57. [PMID: 21757879 DOI: 10.1159/000329024] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2010] [Accepted: 04/16/2011] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Cutaneous scleroderma is a chronic inflammatory disease of the dermal and subcutaneous connective tissue leading to sclerosis. Sclerosis of the skin can lead to dysmorphism, contractures and restrictions of movement. OBJECTIVE The purpose of the study was to evaluate sclerosis in cutaneous scleroderma patients and to determine the efficacy of water-filtered infrared A plus visible light treatment, wIRA(+VIS), in 10 patients. METHODS Hardness of the normal and diseased skin was measured by durometry in 10 controls and 8 patients. Moreover, circumscribed scleroderma (CS) was treated with wIRA(+VIS) irradiations in 10 patients who had not responded to conventional therapies. RESULTS wIRA(+VIS) therapy led to a marked improvement, persistent even during long-term follow-up, in 7 out of 10 patients with CS. Of the other patients, 1 showed decreased sclerosis and disease activity and developed a worsening after cessation of therapy. In 2 further patients, where previous UVA1 treatment had failed to reduce disease activity, wIRA(+VIS) produced a slight decrease in sclerosis, but disease activity was still present. CONCLUSION wIRA(+VIS) appears to be effective in the treatment of CS. Durometry proved to be helpful in assessing the degree of sclerosis and in documenting the response to therapy in these patients.
Collapse
|
96
|
Daubert C, Rude J, Schobersberger W, Hoffmann G. Effektivität der Manuellen Lymphdrainage in der Erhaltungsphase einseitiger, sekundärer Armlymphödeme - Eine Pilotstudie. AKTUELLE DERMATOLOGIE 2011. [DOI: 10.1055/s-0030-1256091] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
97
|
Daubert C, Rude J, Schobersberger W, Hoffmann G. Effektivität der Elastische-Tape-Technik in der Erhaltungsphase einseitiger, sekundärer Armlymphödeme. PHYSIOSCIENCE 2011. [DOI: 10.1055/s-0029-1246081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
98
|
Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Biritz B, Bland LC, Borowski W, Bouchet J, Braidot E, Brandin AV, Bridgeman A, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chajecki Z, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung P, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Dash S, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Derevschikov AA, Derradi de Souza R, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Dunlop JC, Dutta Mazumdar MR, Efimov LG, Elnimr M, Engelage J, Eppley G, Erazmus B, Estienne M, Eun L, Evdokimov O, Fatemi R, Fedorisin J, Fersch RG, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Ganti MS, Geromitsos A, Geurts F, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk O, Grosnick D, Guertin SM, Gupta A, Guryn W, Haag B, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heinz M, Heppelmann S, Hirsch A, Hjort E, Hoffmann GW, Hofman DJ, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Jacobs P, Jacobs WW, Jena C, Jin F, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Knospe AG, Kocoloski A, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Krueger K, Krus M, Kumar L, Kurnadi P, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee CH, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li N, Li W, Li X, Li X, Li Y, Li ZM, Lisa MA, Liu F, Liu H, Liu J, Ljubicic T, Llope WJ, Longacre RS, Love WA, Lu Y, Lukashov EV, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Mangotra LK, Manweiler R, Margetis S, Markert C, Masui H, Matis HS, Matulenko YA, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mischke A, Mitrovski MK, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Naglis M, Nandi BK, Nayak TK, Netrakanti PK, Ng MJ, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Ohlson A, Okorokov V, Oldag EW, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Peitzmann T, Perkins C, Peryt W, Phatak SC, Pile P, Planinic M, Ploskon MA, Pluta J, Plyku D, Poljak N, Poskanzer AM, Potukuchi BVKS, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Rose A, Ruan L, Sakai S, Sakrejda I, Sakuma T, Salur S, Sandweiss J, Sangaline E, Schambach J, Scharenberg RP, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shahaliev E, Shao M, Sharma M, Shi SS, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Sorensen P, Spinka HM, Srivastava B, Stanislaus TDS, Staszak D, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Timoshenko S, Tlusty D, Tokarev M, Trainor TA, Tram VN, Trentalange S, Tribble RE, Tsai OD, Ullrich T, Underwood DG, Van Buren G, van Leeuwen M, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu YF, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yepes P, Yip K, Yoo IK, Yue Q, Zawisza M, Zbroszczyk H, Zhan W, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao J, Zhong C, Zhou W, Zhu X, Zhu YH, Zoulkarneev R, Zoulkarneeva Y. Measurement of the parity-violating longitudinal single-spin asymmetry for W± boson production in polarized proton-proton collisions at sqrt[s] = 500 GeV. PHYSICAL REVIEW LETTERS 2011; 106:062002. [PMID: 21405460 DOI: 10.1103/physrevlett.106.062002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/03/2010] [Indexed: 05/30/2023]
Abstract
We report the first measurement of the parity-violating single-spin asymmetries for midrapidity decay positrons and electrons from W+ and W- boson production in longitudinally polarized proton-proton collisions at sqrt[s] = 500 GeV by the STAR experiment at RHIC. The measured asymmetries, A(L)(W+) = -0.27 ± 0.10(stat.) ± 0.02(syst.) ± 0.03(norm.) and A(L)(W-) = 0.14 ± 0.19(stat.) ± 0.02(syst.) ± 0.01(norm.), are consistent with theory predictions, which are large and of opposite sign. These predictions are based on polarized quark and antiquark distribution functions constrained by polarized deep-inelastic scattering measurements.
Collapse
|
99
|
Schoeneich F, Rahimi A, Hoffmann G, Eide M, Schöttler J, Cremer J. Transatrial left-ventricular cannulation in acute typ A aortic dissection: Save, easy and effective! Thorac Cardiovasc Surg 2011. [DOI: 10.1055/s-0030-1269334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
100
|
Noske A, Loibl S, Darb-Esfahani S, Roller M, Kronenwett R, Müller BM, Steffen J, von Toerne C, Wirtz R, Baumann I, Hoffmann G, Heinrich G, Grasshoff ST, Ulmer HU, Denkert C, von Minckwitz G. Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765). Breast Cancer Res Treat 2010; 126:109-17. [PMID: 21190079 DOI: 10.1007/s10549-010-1316-y] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2010] [Accepted: 12/16/2010] [Indexed: 10/18/2022]
Abstract
Human epidermal growth factor receptor 2 (HER2) testing is an essential part of pathological assessment in breast cancer patients, as HER2 provides not only prognostic but also predictive information on response to targeted therapy. So far, HER2 test accuracy of immunohistochemistry/in situ-hybridization techniques is still under debate, and more reliable and robust technologies are needed. To address this issue and to evaluate the predictive value of HER2 on chemotherapy, we investigated a cohort of 278 patients from the GeparTrio trial, a prospective neoadjuvant anthracycline/taxane-based multicenter study. In the GeparTrio trial, patients were not treated with any anti-HER2 therapy, as this was not standard therapy at this time. The HER2 status was analyzed by three different approaches: local and central evaluation using immunohistochemistry combined with in situ-hybridization as well as evaluation of HER2 mRNA expression using kinetic RT-PCR from formalin-fixed, paraffin-embedded (FFPE) tissue samples using a predefined cutoff. HER2 overexpression/amplification was observed in 37.3% (91/244) and 17.9% (41/229) of the informative samples in the local and central evaluations, respectively. Positive HER2 mRNA levels were found in 19.8% (55/278). We observed a highly significant correlation between central HER2 expression and HER2 status measured by kinetic RT-PCR (r = 0.856, P < 0.0001) and an overall agreement of 95.6% (κ statistic, 0.862, CI 0.77-0.94). Further, central HER2 as well as HER2 mRNA expression were predictors for a pathological complete response after neoadjuvant anthracycline/taxane-based primary chemotherapy in a univariate binary logistic regression analysis (OR 3.29, P = 0.002; OR 2.65, P = 0.004). The predictive value could be confirmed for the central HER2 status by multivariate analysis (OR 3.04, P = 0.027). The locally assessed HER2 status was not predictive of response to chemotherapy. Our results suggest that standardized methods are preferable for evaluation of HER2 status. The kinetic RT-PCR from FFPE tissue might be an additional approach for assessment of this important prognostic and predictive parameter but has to be confirmed by other studies.
Collapse
MESH Headings
- Adult
- Antineoplastic Combined Chemotherapy Protocols/therapeutic use
- Biomarkers, Tumor/genetics
- Biomarkers, Tumor/metabolism
- Breast Neoplasms/drug therapy
- Breast Neoplasms/genetics
- Breast Neoplasms/metabolism
- Capecitabine
- Carcinoma, Ductal, Breast/drug therapy
- Carcinoma, Ductal, Breast/genetics
- Carcinoma, Ductal, Breast/metabolism
- Carcinoma, Lobular/drug therapy
- Carcinoma, Lobular/genetics
- Carcinoma, Lobular/metabolism
- Chemotherapy, Adjuvant
- Cyclophosphamide/administration & dosage
- Deoxycytidine/administration & dosage
- Deoxycytidine/analogs & derivatives
- Docetaxel
- Doxorubicin/administration & dosage
- Female
- Fluorouracil/administration & dosage
- Fluorouracil/analogs & derivatives
- Humans
- Immunoenzyme Techniques
- Neoadjuvant Therapy
- Prognosis
- Prospective Studies
- RNA, Messenger/genetics
- Receptor, ErbB-2/genetics
- Receptor, ErbB-2/metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Rate
- Taxoids/administration & dosage
- Vinblastine/administration & dosage
- Vinblastine/analogs & derivatives
- Vinorelbine
Collapse
|